All In Biotech

Drug Trial Radar · NCT07214779

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

A Phase 3, Randomized, Open-Label Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

13

Actual

Start

Dec 9, 2025

Primary completion

Oct 12, 2027

Study completion Oct 12, 2027

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
Collaborators
ENGOT Foundation; GOG Foundation
First posted
Oct 9, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate INCB123667 versus investigator's choice of chemotherapy in participants with platinum-resistant ovarian cancer with cyclin E1 overexpression.

Conditions

  • Ovarian Cancer

Interventions

  • INCB123667Drug

    Oral; tablet

  • Investigator's choice of chemotherapyDrug

    The investigator will select the chemotherapy in accordance with the protocol-defined requirements. The possible choices as defined by the protocol:

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-Free Survival (PFS) by BICRTime frame: Up to 2 years
  2. Overall Survival (OS)Time frame: Up to 2 years

Locations

198 sites in 16 countries. Site status is shown where the registry gives one.

  • Alaska Womens Cancer Care Akwcc

    Anchorage, Alaska

  • University of Arizona Cancer Center

    Tucson, Arizona

  • City of Hope Medical Center

    Duarte, California

  • Providence Medical Foundation

    Fullerton, California

  • University of California, San Diego-Moores Cancer Center

    La Jolla, California

  • Valkyrie Clinical Trials

    Los Angeles, California

  • Uci Health Chao Family Comprehensive Cancer Center

    Orange, California

  • Ventura County Hematology Oncology Specialists-Oxnard

    Oxnard, California

  • University of Colorado Cancer Center

    Aurora, Colorado

  • Mount Sinai Medical Center Comprehensive Cancer Center

    Miami Beach, Florida

  • Brcr Global

    Miramar, Florida

  • Sarasota Memorial Health Care System

    Sarasota, Florida

  • Winship Cancer Institute At Emory University

    Atlanta, Georgia

  • Georgia Cancer Center

    Augusta, Georgia

  • The University of Chicago Medicine

    Chicago, Illinois

  • Carle Cancer Center

    Effingham, Illinois

  • Northshore University Health System-Evanston Hospital

    Evanston, Illinois

  • City of Hope - Chicago Cancer Center

    Zion, Illinois

  • St Elizabeth Healthcare

    Edgewood, Kentucky

  • Women'S Cancer Care

    Covington, Louisiana

  • Trials365, Llc

    Shreveport, Louisiana

  • Maine Center For Cancer Medicine

    Scarborough, Maine

  • Holy Cross Hospital

    Silver Spring, Maryland

  • Greater Baltimore Medical Center

    Towson, Maryland

  • Henry Ford Cancer - Detroit

    Detroit, Michigan

  • Mercy Hospital St. Louis - David C. Pratt Cancer Center

    St Louis, Missouri

  • Billings Clinic

    Billings, Montana

  • Women'S Cancer Center of Nevada

    Las Vegas, Nevada

  • Center of Hope

    Reno, Nevada

  • Maimonides Medical Center

    Short Hills, New Jersey

  • Unm Comprehensive Cancer Center

    Albuquerque, New Mexico

  • Levine Cancer Center

    Charlotte, North Carolina

  • Novant Presbyterian Hospital

    Charlotte, North Carolina

  • East Carolina University

    Greenville, North Carolina

  • Novant Health Oncology Specialists

    Winston-Salem, North Carolina

  • Atrium Health Wake Forest Baptist

    Winston-Salem, North Carolina

  • Cleveland Clinic Foundation

    Cleveland, Ohio

  • Ohio Health Research Institute

    Columbus, Ohio

  • Miami Valley Hospital South

    Dayton, Ohio

  • Promedica Flower Hospital

    Sylvania, Ohio

Showing 40 of 198 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.